Risk Assessment for Newly Diagnosed Fit Young Patients with Multiple Myeloma in the Era of Novel Treatment Modalities: Should There Be Additional Factors Taken into Consideration??

INTRODUCTION: The optimal treatment for young patients with high-risk newly diagnosed multiple myeloma (NDMM) remains a challenge. METHODS: We retrospectively evaluated 58 NDMM patients younger than 55 years treated in our center from 2010 to 2021 with the current recommended protocols. RESULTS: Aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaloyannidis, Panayotis, Abdulla, Fatema, Mutahar, Enas, Al Hashim, Haidar, Al Harbi, Salman, Estanislao, Analie, Al Hashmi, Hani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617519/
https://www.ncbi.nlm.nih.gov/pubmed/36317167
http://dx.doi.org/10.2147/JBM.S380133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617519/
https://www.ncbi.nlm.nih.gov/pubmed/36317167
http://dx.doi.org/10.2147/JBM.S380133

Ejemplares similares